Among them, the PDGFRA p.Y288C mutation in GBM leads to the constitutive dimerization and phosphorylation of the extracellular domain in the absence of ligand binding, indicating the constitutive activation of Akt, Erk1/2, and STAT322, 29. The gene discussed is MAPK3; the disease is glioblastoma.